(Total Views: 85)
Posted On: 01/27/2020 9:55:40 AM
Post# of 36554
$AKTX News Article - Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases https://marketwirenews.com/news-releases/akar...17465.html
(0)
(0)
My Twitter: WhyteStocks
